Termination Reimbursement scheme Adhesa®
Due to changes in market conditions, the reimbursement scheme for Adhesa will end on 1 May 2026.
Conditions
This means that...
Termination Reimbursement scheme Veoza®
From May 1 st, 2026 onwards, VEOZA® 45 mg is fully reimbursed by the health insurer (exclusively for an insured person with...
Reimbursement Scheme Paxneury® (guanfacine)
The health insurer does not fully reimburse Paxneury® 1 mg, 2 mg, 3 mg, 4 mg tablets. The producer of this medicine has therefore...
TBR Nederland Instructional videos now available
TBR Nederland now has instructional videos available to help patients create an account and submit a claim. The following...
Termination Reimbursement scheme Broxil®
From August 1, 2025 Broxil® 125 mg / 5 mL, powder for oral suspension is fully reimbursed by the health insurance. For this reason...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine